68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases.
Nuklearmedizin
2009
48
5
N52-4
Administration of RAD001 in patients with metastasized renal cell carcinoma
Onkologe
2009
15
5
512-+
SURVIVAL IN PROSTATE CANCER PATIENTS WITH POSITIVE LYMPH NODES DURING RADICAL PROSTATECTOMY - THE ADVANTAGE OF COMPLETED SURGERY
Eur Urol Suppl
2009
8
4
250-250
INDUCTION OF PSA-SPECIFIC CYTOTOXIC T CELLS BY PEPTIDE-BASED IMMUNOTHERAPY
Eur Urol Suppl
2009
8
4
249-249
EMMPRIN (CD147): A POTENTIAL NEW TARGET PROTEIN IN THE TUMOUR PROGRESSION OF BLADDER CANCER
Eur Urol Suppl
2009
8
4
227-227
EXAMINATION OF LYMPH NODES OF MUSCLE-INVASIVE BLADDER CANCER PATIENTS FOR MICROMETASTASES WITH RT-PCR IN COMPARISON WITH HISTOPATHOLOGICAL FINDINGS
Eur Urol Suppl
2009
8
4
197-197
THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-gamma SECRETING ALLOGENEIC TUMORVACCINE
Eur Urol Suppl
2009
8
4
133-133
CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Gut
2009
58
10
1391-8
IMMUNOSTIMULATORY CPG-DNA AND PSA-PEPTIDE VACCINATION ELICITS PROFOUND CYTOTOXIC T CELL RESPONSES
J Urol
2009
181
4
519 -
MOLECULAR STAGING OF LYMPH NODES FROM MUSCLE-INVASIVE BLADDER CANCER PATIENTS BY RT-PCR COMPARED TO PATHOLOGIC FINDINGS - ARE THERE DIFFERENCES IN LOCALIZATION AND DETECTION RATES?
J Urol
2009
181
4
1166 -